257 related articles for article (PubMed ID: 8892619)
1. Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2.
Satoh M; Seki S; Hashimoto W; Ogasawara K; Kobayashi T; Kumagai K; Matsuno S; Takeda K
J Immunol; 1996 Nov; 157(9):3886-92. PubMed ID: 8892619
[TBL] [Abstract][Full Text] [Related]
2. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
3. In vitro expansion of human γδ and CD56(+) T-cells by Aspergillus-antigen loaded fast dendritic cells in the presence of exogenous interleukin-12.
Ramadan G
Immunopharmacol Immunotoxicol; 2012 Apr; 34(2):309-16. PubMed ID: 21854188
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
5. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells.
Perussia B; Chan SH; D'Andrea A; Tsuji K; Santoli D; Pospisil M; Young D; Wolf SF; Trinchieri G
J Immunol; 1992 Dec; 149(11):3495-502. PubMed ID: 1358972
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo expansion of natural killer cells for clinical applications.
Klingemann HG; Martinson J
Cytotherapy; 2004; 6(1):15-22. PubMed ID: 14985163
[TBL] [Abstract][Full Text] [Related]
7. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
[TBL] [Abstract][Full Text] [Related]
8. Values for αβ and γδ T-lymphocytes and CD4+, CD8+, and CD56+ subsets in healthy adult subjects: assessment by age and gender.
Andreu-Ballester JC; García-Ballesteros C; Benet-Campos C; Amigó V; Almela-Quilis A; Mayans J; Ballester F
Cytometry B Clin Cytom; 2012 Jul; 82(4):238-44. PubMed ID: 22539222
[TBL] [Abstract][Full Text] [Related]
9. Targeted cytotoxic cells in human peripheral blood lymphocytes.
Garrido MA; Perez P; Titus JA; Valdayo MJ; Winkler DF; Barbieri SA; Wunderlich JR; Segal DM
J Immunol; 1990 Apr; 144(8):2891-8. PubMed ID: 1691221
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-12 activates human gamma delta T cells: synergistic effect of tumor necrosis factor-alpha.
Ueta C; Kawasumi H; Fujiwara H; Miyagawa T; Kida H; Ohmoto Y; Kishimoto S; Tsuyuguchi I
Eur J Immunol; 1996 Dec; 26(12):3066-73. PubMed ID: 8977306
[TBL] [Abstract][Full Text] [Related]
11. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.
Doherty DG; Norris S; Madrigal-Estebas L; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
J Immunol; 1999 Aug; 163(4):2314-21. PubMed ID: 10438977
[TBL] [Abstract][Full Text] [Related]
12. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.
Lu PH; Negrin RS
J Immunol; 1994 Aug; 153(4):1687-96. PubMed ID: 7519209
[TBL] [Abstract][Full Text] [Related]
13. Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.
Hagihara M; Gansuvd B; Ueda Y; Tsuchiya T; Masui A; Tazume K; Inoue H; Kato S; Hotta T
Cancer Immunol Immunother; 2002 Mar; 51(1):1-8. PubMed ID: 11845254
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of intralymphatic interleukin-2. I. Cytotoxic and surface marker changes of peripheral blood lymphocytes.
Shau H; Isacescu V; Ibayashi Y; Tokuda Y; Golub SH; Fahey JL; Sarna GP
J Biol Response Mod; 1990 Feb; 9(1):71-80. PubMed ID: 2319261
[TBL] [Abstract][Full Text] [Related]
15. Cellular requirements for the activation and proliferation of ruminant gammadelta T cells.
Hanrahan CF; Kimpton WG; Howard CJ; Parsons KR; Brandon MR; Andrews AE; Nash AD
J Immunol; 1997 Nov; 159(9):4287-94. PubMed ID: 9379024
[TBL] [Abstract][Full Text] [Related]
16. Requirement for CD4+ T cells in the gammadelta T cell proliferative response to Daudi Burkitt's lymphoma.
Burns J; Lobo S; Bartholomew B
Cell Immunol; 1996 Nov; 174(1):19-24. PubMed ID: 8929450
[TBL] [Abstract][Full Text] [Related]
17. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 12 (IL-12) is increased in tumour bearing human liver and expands CD8(+) and CD56(+) T cells in vitro but not in vivo.
Kelly AM; Golden-Mason L; McEntee G; Traynor O; Doherty DG; Hegarty JE; O'Farrelly C
Cytokine; 2004 Mar; 25(6):273-82. PubMed ID: 15036243
[TBL] [Abstract][Full Text] [Related]
19. Involvement of CD56brightCD11c+ cells in IL-18-mediated expansion of human γδ T cells.
Tsuda J; Li W; Yamanishi H; Yamamoto H; Okuda A; Kubo S; Ma Z; Terada N; Tanaka Y; Okamura H
J Immunol; 2011 Feb; 186(4):2003-12. PubMed ID: 21239711
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and functional maturation of TCR gammadelta cells in the human thymus.
Offner F; Van Beneden K; Debacker V; Vanhecke D; Vandekerckhove B; Plum J; Leclercq G
J Immunol; 1997 May; 158(10):4634-41. PubMed ID: 9144475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
